These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 3531999)

  • 41. T cell recognized polymorphism associated with HLA-DR2 haplotypes.
    Reinsmoen NL; Bach FH
    Transplant Proc; 1987 Feb; 19(1 Pt 1):839-41. PubMed ID: 3274879
    [No Abstract]   [Full Text] [Related]  

  • 42. The human major histocompatibility complex HLA: some recent developments.
    Thorsby E
    Transplant Proc; 1979 Mar; 11(1):616-23. PubMed ID: 88091
    [No Abstract]   [Full Text] [Related]  

  • 43. Parasite antigen-specific human T cell lines and clones. Major histocompatibility complex restriction and B cell helper function.
    Nutman TB; Ottesen EA; Fauci AS; Volkman DJ
    J Clin Invest; 1984 Jun; 73(6):1754-62. PubMed ID: 6233302
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Human T lymphocyte clones: a new approach for studying relations between the major histocompatibility complex and pathology].
    Levy JP; Sterkers G
    Pathol Biol (Paris); 1986 Jun; 34(6):809-11. PubMed ID: 3531999
    [TBL] [Abstract][Full Text] [Related]  

  • 45. T-cell receptor-major histocompatibility complex genetic interactions in rheumatoid arthritis.
    Gregersen PK
    Rheum Dis Clin North Am; 1992 Nov; 18(4):793-807. PubMed ID: 1280847
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular genetics of the HLA complex.
    Fischer GF; Mayr WR
    Wien Klin Wochenschr; 2001 Oct; 113(20-21):814-24. PubMed ID: 11732117
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunodominance across HLA polymorphism: implications for cancer immunotherapy.
    Kim CJ; Parkinson DR; Marincola F
    J Immunother; 1998 Jan; 21(1):1-16. PubMed ID: 9456431
    [TBL] [Abstract][Full Text] [Related]  

  • 48. T-cell receptor-like antibodies: novel reagents for clinical cancer immunology and immunotherapy.
    Noy R; Eppel M; Haus-Cohen M; Klechevsky E; Mekler O; Michaeli Y; Denkberg G; Reiter Y
    Expert Rev Anticancer Ther; 2005 Jun; 5(3):523-36. PubMed ID: 16250828
    [TBL] [Abstract][Full Text] [Related]  

  • 49. HLA and the role of T cells in the predisposition to disease.
    Stastny P
    Rheum Dis Clin North Am; 1987 Apr; 13(1):1-6. PubMed ID: 2442803
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [MHC tetramers: tracking specific immunity].
    Kosor E; Gagro A; Drazenović V; Kuzman I; Jeren T; Rakusić S; Rabatić S; Markotić A; Gotovac K; Sabioncello A; Cecuk E; Kerhin-Brkljacić V; Gjenero-Margan I; Kaić B; Mlinarić-Galinović G; Kastelan A; Dekaris D
    Acta Med Croatica; 2003; 57(4):255-9. PubMed ID: 14639858
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The association of HLA and disease].
    García-Tamayo F; Faure-Fontenla MA
    Bol Med Hosp Infant Mex; 1989 Sep; 46(9):626-32. PubMed ID: 2481460
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human T cell clones as diagnostic tools and potential therapeutic reagents.
    Weyand C; Goronzy J; Fathman CG
    Immunol Invest; 1986 Nov; 15(7):591-624. PubMed ID: 2433217
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.